European Society of Contraception Statement on Contraception in Obese Women

Gabriele S Merki-Feld; Sven Skouby; David Serfaty; Medard Lech; Johannes Bitzer; Pier Giorgio Crosignani; Angelo Cagnacci; Regine Sitruk-Ware

doi:10.3109/13625187.2014.960561

European Society of Contraception Statement on Contraception in Obese Women

Gabriele S Merki-Feld, Sven Skouby, David Serfaty, Medard Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci, Regine Sitruk-Ware

Institut for Klinisk Medicin

24 Citationer (Scopus)

Abstract

The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

Originalsprog	Engelsk
Tidsskrift	European Journal of Contraception and Reproductive Health Care
Vol/bind	20
Udgave nummer	1
Sider (fra-til)	19-28
Antal sider	10
ISSN	1362-5187
DOI	https://doi.org/10.3109/13625187.2014.960561
Status	Udgivet - 1 feb. 2015

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.3109/13625187.2014.960561

Citationsformater

@article{280983c4fd8441a0a07be66c27502d4a,

title = "European Society of Contraception Statement on Contraception in Obese Women",

abstract = "The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.",

keywords = "Contraception, Contraception, Postcoital, Contraceptive Agents, Female, Developed Countries, Europe, Female, Humans, Intrauterine Devices, Medicated, Obesity, Overweight, Pregnancy, Societies, Medical, Venous Thromboembolism",

author = "Merki-Feld, {Gabriele S} and Sven Skouby and David Serfaty and Medard Lech and Johannes Bitzer and Crosignani, {Pier Giorgio} and Angelo Cagnacci and Regine Sitruk-Ware",

year = "2015",

month = feb,

day = "1",

doi = "10.3109/13625187.2014.960561",

language = "English",

volume = "20",

pages = "19--28",

journal = "The European Journal of Contraception and Reproductive Health Care",

issn = "1362-5187",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - European Society of Contraception Statement on Contraception in Obese Women

AU - Merki-Feld, Gabriele S

AU - Skouby, Sven

AU - Serfaty, David

AU - Lech, Medard

AU - Bitzer, Johannes

AU - Crosignani, Pier Giorgio

AU - Cagnacci, Angelo

AU - Sitruk-Ware, Regine

PY - 2015/2/1

Y1 - 2015/2/1

N2 - The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

AB - The obesity 'epidemic' continues to increase, mostly but not only in developed countries. As overweight and obese women are at an increased risk for venous thromboembolism (VTE) at baseline and at a much higher risk during pregnancy, it is essential to help these women to plan pregnancies carefully and to use contraceptives with a positive ratio of benefits versus risks. The Expert Group on hormonal and molecular contraception of the European Society of Contraception convened to review the existing evidence and propose recommendations to the prescribers in line with most recent studies and with the Medical Eligibility Criteria of the World Health Organisation.

KW - Contraception

KW - Contraception, Postcoital

KW - Contraceptive Agents, Female

KW - Developed Countries

KW - Europe

KW - Female

KW - Humans

KW - Intrauterine Devices, Medicated

KW - Obesity

KW - Overweight

KW - Pregnancy

KW - Societies, Medical

KW - Venous Thromboembolism

U2 - 10.3109/13625187.2014.960561

DO - 10.3109/13625187.2014.960561

M3 - Journal article

C2 - 25380138

SN - 1362-5187

VL - 20

SP - 19

EP - 28

JO - The European Journal of Contraception and Reproductive Health Care

JF - The European Journal of Contraception and Reproductive Health Care

IS - 1

ER -

European Society of Contraception Statement on Contraception in Obese Women

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater